Sharp Corp. buy krebskrebs
Start price
17.05.22
/
50%
€1.88
Target price
17.05.23
€2.20
Performance (%)
-24.47%
End price
18.05.23
€1.42
Summary
This prediction ended on 18.05.23 with a price of €1.42. The price of Sharp Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -24.47%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Sharp Corp. | - | - | - |
iShares Core DAX® | -1.226% | 2.804% | 14.933% |
iShares Nasdaq 100 | -1.845% | 2.732% | 26.075% |
iShares Nikkei 225® | -1.132% | -2.218% | 5.361% |
iShares S&P 500 | -0.980% | 1.883% | 22.727% |
Comments by krebskrebs for this prediction
In the thread Sharp Corp. diskutieren
Buy mit Kursziel 2,2
In the thread Trading Sharp Corp.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten